Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL

Early response to induction chemotherapy is an important prognostic factor in B-lymphoblastic leukemia (B-ALL). Here, we compare high-throughput sequencing (HTS) of IGH and TRG genes vs flow cytometry (FC) for measurable residual disease (MRD) detection at the end of induction chemotherapy in pediat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Wood, Brent, Wu, David, Crossley, Beryl, Dai, Yunfeng, Williamson, David, Gawad, Charles, Borowitz, Michael J., Devidas, Meenakshi, Maloney, Kelly W., Larsen, Eric, Winick, Naomi, Raetz, Elizabeth, Carroll, William L., Hunger, Stephen P., Loh, Mignon L., Robins, Harlan, Kirsch, Ilan
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2018
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5865233/
https://ncbi.nlm.nih.gov/pubmed/29284596
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-09-806521
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars